Long-acting antiretrovirals and HIV treatment adherence
Jean B. Nachega(University of Pittsburgh), John W. Mellors(Textron Systems (United Kingdom)), Monica Gandhi(University of California, San Francisco), Sharon Nachman(State University of New York), Angeli Rawat(University of British Columbia), Elvin Geng(Washington University in St. Louis), Rachel K. Scott(MedStar Health), Moherndran Archary(Africa Health Research Institute), Lynne Mofenson(Elizabeth Glaser Pediatric AIDS Foundation), Kimberly K. Scarsi(University of Nebraska Medical Center), Eric Decloedt(Stellenbosch University), Lindsay Wilson(The University of Texas Health Science Center at Houston)
Cited by 136
Related Papers
Treatment with Indinavir, Zidovudine, and Lamivudine in Adults with Human Immunodeficiency Virus Infection and Prior Antiretroviral Therapy
|New England Journal of Medicine|1997|1.9k
Intrapartum and neonatal single-dose nevirapine compared with zidovudine for prevention of mother-to-child transmission of HIV-1 in Kampala, Uganda: HIVNET 012 randomised trial
|The Lancet|1999|1.7k
Antiretroviral-Drug Resistance among Patients Recently Infected with HIV
|New England Journal of Medicine|2002|1.1k
Combination Antiretroviral Strategies for the Treatment of Pregnant HIV-1–Infected Women and Prevention of Perinatal HIV-1 Transmission
|JAIDS Journal of Acquired Immune Deficiency Syndromes|2002|896